Cell culture is growing cells in an artificially controlled environment. Later, the cells of interest are isolated and further used for various applications such as monoclonal antibody production, vaccine production, therapeutic protein production, cell and gene therapy, and drug screening & development.
Meticulous Research®, in its latest publication on the Cell Culture Market, states that the market is expected to reach $48.63 billion by 2029, at a CAGR of 11.7% from 2022 to 2029.
The growth of this market is driven by factors such as the growing demand for monoclonal bodies, increasing prevalence of chronic diseases, funding for cell-based research, rising adoption of single-use technologies, growing demand for biopharmaceuticals, and increase in R&D spending in the life science sector. Furthermore, the growing adoption of 3D cell culture and personalized medicine to offer new growth potential are expected to provide significant opportunities for the growth of this market. However, disposal of plastic waste generated from single-use technologies, cell line misidentification and cross contamination, and reproducibility of results challenge the growth of the market up to a certain extent.
Download Free Report Sample Now
To provide efficient analysis, Meticulous Research® has segmented this market based on Product [Consumables (Media {Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media}, {Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media}, {Cell Culture Media; Source-Chemically Defined Media, Serum-free Media, Classical Media, Xeno-free/Animal Component Free, Other Cell Culture Media}), Reagents (Growth Factors And Cytokines, Cryoprotective Reagents, Antibiotics/ Antimycotics, Cell Dissociation Reagents, Buffers, Balanced Salt Solutions, Attachment And Matrix Factors, Other Cell Culture Reagents), Cells And Cell Lines, Sera (Fetal Bovine Serum, Other Sera), Cell Culture Vessels (Cell Culture Dishes, Cell Culture Plates, Cell Culture Flasks, Roller Bottles, Other Cell Culture Vessels)) Equipment (Cryopreservative Containers, Refrigerators And Freezers, Biosafety Cabinets, Incubators, Sterilizers, Bioreactors, Microscopes, Centrifuges, Cell Counters, Water Baths, Other Equipment)]; Application [Bioproduction (Monoclonal Antibody Production, Therapeutic Protein Production, Vaccine Production, Cell And Gene Therapy)], Diagnostics, Cancer Research, Drug Screening And Development, Stem Cell Research); End User (Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Diagnostic Laboratories); and Geography (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa).
Based on geography, in 2022, North America is estimated to account for the largest share of the cell culture market, followed by Europe and Asia-Pacific. However, countries in Asia-Pacific, particularly China, are slated to register the highest growth rate during the forecast period. A growing population is a key factor driving this region’s healthcare & pharmaceutical sector, which draws a lot of investment from government & non-government bodies. The countries are aiming to become competitive in the global biotech market, paving the way for a lot of research & development activities in this domain. Additionally, the increased investments are propelling the demand for cell culture products across the Asia-Pacific region.
Based on product, in 2022, the consumables segment is estimated to account for the largest share of the cell culture market. Factors contributing to the large market share of this segment are the increase in the use of cell culture techniques that need the continuous supply of consumbles for cell culturing by the pharmaceutical and biopharmaceutical companies and research institutes. Cell culture is a long process where a change of media or reagents is required while subculturing or isolating a specific cell type. This, too, requires plates and flasks to support cell growth.
Based on application, in 2022, the bioproduction segment is estimated to account for the largest share of the cell culture market. Factors such as the growing research for novel products such as therapeutic proteins, vaccines, cell and gene therapy products, government support for research, and rising corporate funding for biotechnology-based start-ups contribute to market growth.
Based on end user, in 2022, the pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the cell culture market. The expansion of the biotherapeutics market is observed due to the commercial success of antibody therapeutics and emerging biosimilars, resulting in the increased demand for biotherapeutic products. These products contribute to the rise in usage of cell culture products by pharmaceutical and biotechnology companies.
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence of some of the key players in this market, such as Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Miltenyi Biotec B.V. & Co. KG (Germany), and Solida Biotech GmBH (Germany).
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/cell-culture-market-4788
Author:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research